Keratocan (KERA) (C-Term) Peptide
KERA
Reactivité: Humain, Souris
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits KERA
- KERA (Keratocan (KERA))
- Protein Region
- C-Term
- Origine
- Humain, Souris
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- MQLNMAKNAL RNMPPRLPAN TMQLFLDNNS IEGIPENYFN VIPKVAFLRL
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-Kera Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- KERA (Keratocan (KERA))
- Synonymes
- KERA Peptide, si:dkeyp-38g8.3 Peptide, zgc:136259 Peptide, CNA2 Peptide, SLRR2B Peptide, keratocan Peptide, KERA Peptide, kera Peptide, Kera Peptide
- Sujet
-
Kera may be important in developing and maintaining corneal transparency and for the structure of the stromal matrix.
Alias Symbols: CNA2, SLRR2B
Protein Size: 351 - Poids moléculaire
- 39 kDa
- ID gène
- 16545
- NCBI Accession
- NM_008438, NP_032464
- UniProt
- O35367
-
Vous êtes ici:
